where it induces transcription of a number of cytoprotective genes.
In their comprehensive review, Baird and DinkovaKostova (2011) present different models of regulation, such as the 'sequester and release model' for Keap1-Nrf2, the role of cullin 3 during dissociation, the hinge and latch model, sensing of inducers by Nrf2 and the role of phosphorylation. Moreover, a comprehensive overview of cytoprotective Nrf2 target genes and the chemistry of inducers are provided. In a complementary review, Slocum and Kensler (2011) focus on genetic mouse models of the Keap 1-Nrf2 pathway and its role in carcinogenesis of the colon, bladder, lung, stomach, skin, liver and breast. Upregulation of Nrf2 signaling provides tumor cells with a survival advantage in adverse environments (Slocum and Kensler 2011). Moreover, Nrf2 also upregulates the expression of the multidrug-resistant protein-3 (MRP3), which exports a variety of cytostatic drugs, including chlorambucil, cisplatin, doxorubicin and etoposide.
Further influential articles published in the Archives of Toxicology in recent years focus on nanotoxicity (Kim et al. 2012; Landsiedel et al. 2012; Nunes et al. 2012; Trpkovic et al. 2012; Gebel 2012; Oesch and Landsiedel 2012) , the use of stem cells in toxicology (Wobus and Löser 2011; Krug et al. 2013; Seiler et al. 2011 ), carcinogenesis (Bernstein et al. 2011 Golka et al. 2011; Burns and Korach 2012; Pavanello and Lotti 2012; Brambilla et al. 2011 ), metal toxicology (Chasapis et al. 2012 , neurotoxicity (Soderlund 2012; Carvalho et al. 2012; Mariussen 2012) , in silico and in vitro methods (Karp and Caspi 2011; Godoy et al. 2013; Mehling et al. 2012; Geenen et al. 2012 ) and oxidative stress (Matés et al. 2012) . The editors hope that this choice meets the current needs of our readers, and encourage them to suggest further In 1988, Paul Talalay and colleagues described a protein with highly reactive cysteine residues that protects against chemical carcinogenesis (Talalay et al. 1988) This led to the discovery of an elaborate network of highly inducible, cytoprotective proteins that are controlled by the Keap1-Nrf2 pathway (Itoh et al. 1999; Dinkova-Kostova et al. 2002; Kobayashi et al. 2004; Wakabayashi et al. 2004; Motohashi and Yamamoto 2004; Zhang and Hannink 2003; Balogun et al. 2003; McMahon et al. 2003; Zhang et al. 2004; Kwak et al. 2003) . In the following decades, the Keap1-Nrf2-signaling axis became one of the most studied topics in toxicology. Therefore, it comes as no surprise that two of the most discussed invited reviews published in the Archives of Toxicology highlight the importance of this pathway (Baird and Dinkova-Kostova 2011; Slocum and Kensler 2011) ( (2011) An expert panel estimated the time necessary to achieve full replacement of animal testing. Time frames of 7-9 and 5-7 years are discussed for skin sensitization and toxicokinetics, respectively. However, a timeline cannot be estimated for repeated-dose toxicity, carcinogenicity and reproductive toxicity 63 Adler et al. (2011) Inorganic selenium interacts with endogenous -SH groups, thus explaining some of its toxicological effects. The potential use of organoselenium as a therapeutic has not yet been sufficiently explored 52 Nogueira and Rocha (2011) Many studies with Nrf-2 knockout mice demonstrate its key role in carcinogenesis of the colon, bladder, lung and stomach, and its relevance to inflammation control 39 Slocum and Kensler (2011) Gas or liquid chromatography coupled to mass spectrometry allows the quantification of thousands of metabolites. However, despite intensive research in the field of metabolomics, no metabolites have been successfully introduced into routine clinical practice. This review critically discusses the state of the art in the field of inborn errors of metabolism, cardiovascular disease and cancer 38 Mamas et al. (2011) The micronucleus assay is used to detect aneugens and clastogens. The 'cytokinesis-block micronucleus assay' evaluates nucleoplasmic bridges, cell division inhibition, nuclear buds, apoptosis and necrosis. This review gives an overview of current protocols, high-throughput methods and the biological background of the micronucleus assay 
